| Breast Cancer |
1 |
1 |
| Genomic Medicine |
0 |
0.99 |
| Triple Negative Breast Cancer |
0 |
0.77 |
| Estrogen Receptor-Positive (ER+) Breast Cancer |
0 |
0.74 |
| Cancer |
0 |
0.62 |
| Breast |
0 |
0.59 |
| Ovarian Cancer |
0 |
0.52 |
| Genetic Testing |
0 |
0.98 |
| COVID-19 |
0 |
0.47 |
| Genetics |
0 |
0.41 |
| Canada |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Poly ADP-Ribose Polymerase (PARP) Inhibitor |
0 |
0.06 |